Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $40.0000 (-1.48%) ($39.0000 - $40.2000) on Wed. Aug. 20, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.56% (three month average) | RSI | 57 | Latest Price | $40.0000(-1.48%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.5% a day on average for past five trading days. | Weekly Trend | CAPR declines -0.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) JNK(7%) PEJ(7%) VT(7%) XLF(7%) EWG(6%) | Factors Impacting CAPR price | CAPR will decline at least -1.78% in a week (0% probabilities). VIXM(-5%) TLT(-4%) UUP(-2%) GLD(-2%) SLV(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.78% (StdDev 3.56%) | Hourly BBV | 0 () | Intraday Trend | -0.5% | | | |
|
Resistance Level | $41.76 | 5 Day Moving Average | $41.02(-2.49%) | 10 Day Moving Average | $41.66(-3.98%) | 20 Day Moving Average | $41.76(-4.21%) | To recent high | -21.6% | To recent low | 3.9% | Market Cap | $788m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |